Suchergebnisse - (Subject:"Siltuximab")

PubPharm (20)

1

Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Valery, M. | Saleh, K. | Ecea, R. | +11

2

The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective

enthalten in: Casopis lekaru ceskych | 2023

von Milota, T. | Střížová, Z. | Sobotková, M. | +1

3

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

4

Multicentric Castlemans disease. Symptoms, diagnostics and therapy

enthalten in: Vnitrni lekarstvi | 2022

von Adam, Z. | Řehák, Z. | Adamová, Z. | +9

5

A BRIEF SYNOPSIS OF MONOCLONAL ANTIBODY FOR THE TREATMENT OF VARIOUS GROUPS OF DISEASES

enthalten in: World journal of pharmacy and pharmaceutical sciences | 2021

von Puthenpurail, A. | Rathi, H. | Nauli, S. | +1

6

Morbus Castleman – ein seltenes, heterogenes Krankheitsbild

enthalten in: Best practice Onkologie | 2021

von Hoffmann, C. | Tepel, J. | Tiemann, M.

7

Unicentric Castlemans disease. Symptoms, diagnostics and therapy

enthalten in: Vnitrni lekarstvi | 2021

von Adam, Z. | Řehák, Z. | Adamová, Z. | +8

8

Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19

enthalten in: Infectious diseases and therapy | 2020

von Meletiadis, J. | Tsiodras, S. | Tsirigotis, P.

9

Population pharmacokinetics of siltuximab: impact of disease state

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Nikanjam, M. | Yang, J. | Capparelli, E.

10

Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature

enthalten in: Magyar onkologia | 2018

von Szegedi, I. | Gáspár, I. | Gyurina, K. | +2